Jaramillo, S., Krisam, J., Le Cornet, L., Kratzmann, M., Baumann, L., Kayser, S., Schliemann, C., Kaufmann, M., Kieser, M., Platzbecker, U., Müller-Tidow, C. and Schlenk, R. F. (2020) “Multicenter upfront randomized phase II trial of quizartinib and high-dose cytarabine plus mitoxantrone in relapsed/refractory acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplication”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.288362.